About this Webinar
Join Oncology & Hematology Analyst, Jessica McCormack, and Senior Director of Oncology and Hematology, Fern Barkalow, for an overview of the current melanoma treatment landscape, with insights from our recently published report, Melanoma: Global Drug Forecast and Market Analysis to 2029.
This approximately 45-minute webinar will answer the following:
• What are the current treatment options for melanoma patients? How do these compare across the 8 major markets?
• What are the key R&D strategies, growth drivers, and barriers in the melanoma market across the 8 major markets?
• What are the most promising pipeline agents and what are their future prospects? How do these relate to the unmet needs identified by KOLs?
Speakers
Jessica McCormack, PhD
Jessica McCormack, PhD, is an Oncology and Hematology Analyst at GlobalData. Prior to her role at GlobalData, she worked as a freelance scientific editor, providing copywriting and editorial assistance to a range of clients. Jessica undertook postdoctoral research at UCL in cardiovascular biology, completed her PhD at Imperial College London in cell biology, and has a Masters of Research in Molecular Medicine from Imperial.
Fern Barkalow, PhD
Fern Barkalow, PhD, is the Senior Director of Oncology and Hematology at GlobalData in Boston. She has over 20 years of experience in the biopharmaceutical industry, as well as a research background in molecular mechanisms of inflammation and metastasis. After leaving the lab bench, Fern moved into the database group at Incyte Pharmaceuticals where she helped develop the Proteome BioKnowledge Library and led a cross-functional team tasked with creating databases covering diseases and molecular interactions. Fern was also Associate Director of the Oncology team at Citeline, where she developed and managed the Trialtrove database and interacted with clients through research support and custom analytics projects.
Past Webinars
View more past webinarsUpcoming Webinars
View more upcoming webinarsSearch companies, themes, reports, as well as actionable data & insights spanning 22 global industries
Access more premium companies when you subscribe to Explorer


